D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Artivion
AORT
$1.31B
| $1.82M | ﹤0.01% |
101,603
+34,985
| +53% | +$544K |
|
2602
UDR
UDR
$12.7B
| $1.81M | ﹤0.01% |
47,198
-36,596
| -44% | -$1.27M |
|
|
CIO
2603
DELISTED
City Office REIT
CIO
| $1.8M | ﹤0.01% |
295,249
+82,074
| +39% | +$383K |
|
2604
CALL
PG&E
PCG
$39.2B
| $1.8M | ﹤0.01% |
100,000
| – | – |
|
2605
CALL
Royal Gold
RGLD
$16.6B
| $1.8M | ﹤0.01% |
14,900
| – | – |
|
|
LTHM
2606
PUT
DELISTED
Livent Corporation
LTHM
| $1.8M | ﹤0.01% |
+100,200
| New | +$1.56M |
|
2607
PUT
Camping World
CWH
$399M
| $1.8M | ﹤0.01% |
68,600
+8,600
| +14% | +$180K |
|
2608
CALL
Enovix
ENVX
$866M
| $1.79M | ﹤0.01% |
163,657
-102,400
| -38% | -$1.01M |
|
2609
Scholar Rock
SRRK
$5.92B
| $1.79M | ﹤0.01% |
95,291
+26,469
| +38% | +$329K |
|
2610
EQT Corp
EQT
$32.3B
| $1.79M | ﹤0.01% |
46,276
-127,082
| -73% | -$5.15M |
|
2611
CALL
Dave & Buster's
PLAY
$361M
| $1.79M | ﹤0.01% |
33,200
+600
| +2% | +$24.3K |
|
2612
CALL
MGM Resorts International
MGM
$11.8B
| $1.79M | ﹤0.01% |
40,000
-94,600
| -70% | -$3.71M |
|
2613
CALL
Cboe Global Markets
CBOE
$31.1B
| $1.79M | ﹤0.01% |
+10,000
| New | +$1.71M |
|
2614
Perion Network
PERI
$378M
| $1.79M | ﹤0.01% |
57,833
-2,363
| -4% | -$67.1K |
|
2615
Wynn Resorts
WYNN
$10.3B
| $1.78M | ﹤0.01% |
19,550
-188,089
| -91% | -$16.7M |
|
|
ITOS
2616
DELISTED
iTeos Therapeutics
ITOS
| $1.77M | ﹤0.01% |
162,058
+47,600
| +42% | +$472K |
|
2617
YPF
YPF
$19.5B
| $1.77M | ﹤0.01% |
103,224
+75,494
| +272% | +$1.04M |
|
2618
PUT
Thor Industries
THO
$4.13B
| $1.77M | ﹤0.01% |
15,000
| – | – |
|
2619
GeoPark
GPRK
$601M
| $1.77M | ﹤0.01% |
206,559
-43,392
| -17% | -$410K |
|
|
ZYXI
2620
DELISTED
Zynex
ZYXI
| $1.77M | ﹤0.01% |
162,296
+98,849
| +156% | +$880K |
|
2621
PUT
Bunge Global
BG
$22.8B
| $1.77M | ﹤0.01% |
17,500
-43,800
| -71% | -$4.59M |
|
|
APLS
2622
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $1.77M | ﹤0.01% |
29,500
| – | – |
|
2623
CALL
Chubb
CB
$141B
| $1.76M | ﹤0.01% |
7,800
-2,200
| -22% | -$481K |
|
2624
Cimpress
CMPR
$2.43B
| $1.76M | ﹤0.01% |
21,978
+4,205
| +24% | +$293K |
|
2625
Titan International
TWI
$530M
| $1.76M | ﹤0.01% |
118,178
+24,580
| +26% | +$324K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.